カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の感染症体外診断市場2023-2030：製品別（機器、試薬、ソフトウェア）、技術別、用途別、検査場所別、地域別

【英語タイトル】Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Software), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN005）・商品コード：GRV23JUN005
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月16日
・ページ数：200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界の感染症体外診断市場規模が、予測期間中（2023年～2030年）に年平均-11.5％減少し、2030年までに326.3億ドルへ達すると見込まれています。本調査書では、感染症体外診断の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、製品別（機器、試薬、ソフトウェア）分析、技術別（イムノアッセイ、分子診断法、ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、その他）分析、用途別（MRSA、クロストリジウムディフィシル、バンコマイシン耐性腸球菌（VRE）、カルバペネム耐性腸内細菌科細菌（CRE）、その他）分析、検査場所別（ポイントオブケア（診療現場）、中央研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、BD、bioMérieux SA、Abbott、Quidel Corporation、OraSure Technologies, Inc、Hologic Inc. (Gen Probe)、Cepheid (Danaher)、QIAGEN、F. Hoffmann-La Roche Ltd.、Siemens Healthcare GmbH、Bio-Rad Laboratories, Inc.などが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界感染症体外診断の市場規模：製品別
- 機器の市場規模
- 試薬の市場規模
- ソフトウェアの市場規模
・世界感染症体外診断の市場規模：技術別
- イムノアッセイにおける市場規模
- 分子診断法における市場規模
- ポリメラーゼ連鎖反応（PCR）における市場規模
- 等温核酸増幅技術（INAAT）における市場規模
- その他技術における市場規模
・世界感染症体外診断の市場規模：用途別
- MRSAにおける市場規模
- クロストリジウムディフィシルにおける市場規模
- バンコマイシン耐性腸球菌（VRE）における市場規模
- カルバペネム耐性腸内細菌科細菌（CRE）における市場規模
- その他用途における市場規模
・世界感染症体外診断の市場規模：検査場所別
- ポイントオブケア（診療現場）における市場規模
- 中央研究所における市場規模
- その他検査場所における市場規模
・世界感染症体外診断の市場規模：地域別
- 北米の感染症体外診断市場規模
- ヨーロッパの感染症体外診断市場規模
- アジア太平洋の感染症体外診断市場規模
- 中南米の感染症体外診断市場規模
- 中東・アフリカの感染症体外診断市場規模
・競争状況

感染症体外診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の感染症体外診断市場規模は2030年までに326.3億米ドルに達する見込みです。2023年から2030年までのCAGRは-11.5%で減少すると予測されています。結核やCOVID-19などの感染症の流行の高まりと技術の進歩が、今後数年間の製品需要を牽引するとみられています。また、多剤耐性感染症の増加により、感染症の早期診断が強化されています。例えば、2021年のMicrobial Drug Resistance Journalによると、重症のSARS-CoV-2患者におけるMDR感染症の有病率は14%～50%でした。

感染診断前の診断と抗生物質による治療の遅れは、薬剤耐性菌の蔓延をさらにエスカレートさせ、業界の成長に有利な機会を生み出しています。業界では、消費者の需要に応えるため、数多くの製品が発売されています。例えば、2022年5月、BDは米国で感染症用自動診断プラットフォームを発表しました。このシステムは1700検体のローディングを可能にし、検体の選別の必要性も排除されるため、エラーが減少します。競合各社が提供する製品は戦略的な価格設定により競争力を高めています。

しかし、感度と信念の違いにより、消費者がPoC検査とラボベースの検査のどちらかを選択しなければならない場合、購買行動の複雑さは顕著に増大します。業界は、Hoffmann-La Roche社、Alere社、bioMérieux社、BD社などの企業がシェアの大半を占める寡占状態です。世界の業界は価格に敏感で、費用対効果が高く効率的な製品を製造するという点で、企業間に厳しい競争が生じています。予測期間中、新規バイオマーカーキットの発売が予想されるため、競争は激化するとみられます。競合各社は、より高い市場シェアを獲得するため、製品の発売や認知度向上プログラムの実施など、重要な戦略を採用しています。

感染症体外診断市場レポートハイライト

– 試薬製品セグメントは、検査における大量使用により、2022年に最大の売上シェアを占めました。

– 分子診断薬セグメントは、同セグメントにおける製品上市数の増加、および高精度による採用の増加により、2022年に最大のシェアを獲得しました。

– 用途別では、COVID-19分野が2022年に業界を独占しましたが、これはウイルスの蔓延を抑えるための検査への支出が多いためです。

– 中央検査室セグメントは2022年に最も高い収益シェアを占めましたが、これは検査室ベースの検査の精度が高く、PoCや家庭での検査に比べて信頼性が高いためであり、これらの検査は他の2つのセグメントよりも競争優位性があります。

– 北米地域は、良好な規制の枠組み、予防・早期検査への注力、新規診断薬の採用率の高さにより、2022年に世界市場で首位に立ちました。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product
1.1.1.2 Technology
1.1.1.3 Application
1.1.1.4 Test Location
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.3 Competitive Insights
Chapter 3 IVD Infectious Disease Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.3.3 List of key end users
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Growing geriatric population
3.4.1.2 Technological advancements
3.4.1.3 High demand for PoC facilities
3.4.1.4 Increasing prevalence of infectious diseases
3.4.1.5 External funding for R&D activities
3.4.2 Market restraint analysis
3.4.2.1 High prices of IVD tests
3.4.3 Industry challenges
3.4.3.1 Presence of ambiguous regulatory framework
3.5 IVD Infectious Disease Market Analysis Tools
3.5.1 Industry analysis – Porter’s
3.5.2 PESTLE Analysis
3.5.3 Market entry strategies
Chapter 4 IVD Infectious Diseases Market – Segment Analysis, By Product, 2018 – 2030 (USD Billion)
4.1 Global IVD Infectious Diseases Market: Test Type Movement Analysis
4.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.2.1 Instruments
4.2.1.1 Instruments market estimates and forecast, 2018 – 2030 (USD Billion)
4.2.2 Reagents
4.2.2.1 Reagents market estimates and forecast, 2018 – 2030 (USD Billion)
4.2.3 Software
4.2.3.1 Software market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 5 IVD Infectious Diseases Market – Segment Analysis, By Technology, 2018 – 2030 (USD Billion)
5.1 Global IVD Infectious Diseases Market: Technology Movement Analysis
5.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.2.1 Immunoassay
5.2.1.1 Immunoassay market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2 Molecular diagnostics
5.2.2.1 Molecular diagnostics market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.3 Polymerase Chain Reaction (PCR)
5.2.2.3.1 PCR market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.4 In Situ Hybridization
5.2.2.4.1 In situ hybridization market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.2.2.5.1 INAAT market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.6 Chips and Microarrays
5.2.2.6.1 Chips and microarrays market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.7 Sequencing & NGS
5.2.2.7.1 Sequencing & NGS market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.8 Transcription Mediated Amplification (TMA)
5.2.2.8.1 TMA market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.2.9 Others
5.2.2.9.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.3 Microbiology
5.2.3.1 Microbiology market estimates and forecast, 2018 – 2030 (USD Billion)
5.2.4 Others
5.2.4.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 6 IVD Infectious Diseases Market – Segment Analysis, By Application, 2018 – 2030 (USD Billion)
6.1 Global IVD Infectious Diseases Market: Application Movement Analysis
6.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.2.1 MRSA
6.2.1.1 MRSA market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.2 Streptococcus
6.2.2.1 Streptococcus market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.3 Clostridium difficile
6.2.3.1 Clostridium difficile market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.4 Vancomycin-resistant enterococci (VRE)
6.2.4.1 VRE market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.5 Carbapenem-resistant enterobacterial testing (CRE)
6.2.5.1 CRE market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.6 Respiratory virus
6.2.6.1 Respiratory virus market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.7 Candida
6.2.7.1 Candida market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.8 Tuberculosis (TB) & drug-resistant TB
6.2.8.1 TB & drug-resistant TB market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.9 Gastrointestinal (GI) panel testing
6.2.9.1 GI panel testing market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.10 Chlamydia
6.2.10.1 Chlamydia market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.11 Gonorrhea
6.2.11.1 Gonorrhea market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.12 Human papillomavirus (HPV)
6.2.12.1 HPV market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.13 Human immunodeficiency virus (HIV)
6.2.13.1 HIV market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.14 Hepatitis C
6.2.14.1 Hepatitis C market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.15 Hepatitis B
6.2.15.1 Hepatitis B market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.16 COVID-19
6.2.16.1 COVID-19 market estimates and forecast, 2018 – 2030 (USD Billion)
6.2.17 Others
6.2.17.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 7 IVD Infectious Diseases Market – Segment Analysis, By Test Location, 2018 – 2030 (USD Billion)
7.1 Global IVD Infectious Diseases Market: Test Location Movement Analysis
7.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.2.1 Point of Care
7.2.1.1 Point of Care market estimates and forecast, 2018 – 2030 (USD Billion)
7.2.2 Central laboratories
7.2.2.1 Central laboratories market estimates and forecast, 2018 – 2030 (USD Billion)
7.2.3 Others
7.2.3.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 8 IVD Infectious Diseases Market – Segment Analysis, By Region, 2018 – 2030 (USD Billion)
8.1 Regional Market Snapshot
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.1.2 U.S.
8.1.1.2.1 U.S. IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.1.2.2 Key country dynamics
8.1.1.2.3 Disease prevalence
8.1.1.2.4 Regulatory framework
8.1.1.2.5 Competitive scenario
8.1.1.3 Canada
8.1.1.3.1 Canada IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.1.3.2 Key country dynamics
8.1.1.3.3 Disease prevalence
8.1.1.3.4 Regulatory framework
8.1.1.3.5 Competitive scenario
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.2 UK
8.1.2.2.1 UK IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.2.2 Key country dynamics
8.1.2.2.3 Disease prevalence
8.1.2.2.4 Regulatory framework
8.1.2.2.5 Competitive scenario
8.1.2.3 Germany
8.1.2.3.1 Germany IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.3.2 Key country dynamics
8.1.2.3.3 Disease prevalence
8.1.2.3.4 Regulatory framework
8.1.2.3.5 Competitive scenario
8.1.2.4 Spain
8.1.2.4.1 Spain IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.4.2 Key country dynamics
8.1.2.4.3 Disease prevalence
8.1.2.4.4 Regulatory framework
8.1.2.4.5 Competitive scenario
8.1.2.5 France
8.1.2.5.1 France IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.5.2 Key country dynamics
8.1.2.5.3 Disease prevalence
8.1.2.5.4 Regulatory framework
8.1.2.5.5 Competitive scenario
8.1.2.6 Italy
8.1.2.6.1 Italy IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.6.2 Key country dynamics
8.1.2.6.3 Disease prevalence
8.1.2.6.4 Regulatory framework
8.1.2.6.5 Competitive scenario
8.1.2.7 Denmark
8.1.2.7.1 Denmark IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.7.2 Key country dynamics
8.1.2.7.3 Disease prevalence
8.1.2.7.4 Regulatory framework
8.1.2.7.5 Competitive scenario
8.1.2.8 Sweden
8.1.2.8.1 Sweden IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.8.2 Key country dynamics
8.1.2.8.3 Disease prevalence
8.1.2.8.4 Regulatory framework
8.1.2.8.5 Competitive scenario
8.1.2.9 Norway
8.1.2.9.1 Norway IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.2.9.2 Key country dynamics
8.1.2.9.3 Disease prevalence
8.1.2.9.4 Regulatory framework
8.1.2.9.5 Competitive scenario
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.2 Japan
8.1.3.2.1 Japan IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.2.2 Key country dynamics
8.1.3.2.3 Disease prevalence
8.1.3.2.4 Regulatory framework
8.1.3.2.5 Competitive scenario
8.1.3.3 China
8.1.3.3.1 China IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.3.2 Key country dynamics
8.1.3.3.3 Disease prevalence
8.1.3.3.4 Regulatory framework
8.1.3.3.5 Competitive scenario
8.1.3.4 India
8.1.3.4.1 India IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.4.2 Key country dynamics
8.1.3.4.3 Disease prevalence
8.1.3.4.4 Regulatory framework
8.1.3.4.5 Competitive scenario
8.1.3.5 South Korea
8.1.3.5.1 South Korea IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.5.2 Key country dynamics
8.1.3.5.3 Disease prevalence
8.1.3.5.4 Regulatory framework
8.1.3.5.5 Competitive scenario
8.1.3.6 Australia
8.1.3.6.1 Australia IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.6.2 Key country dynamics
8.1.3.6.3 Disease prevalence
8.1.3.6.4 Regulatory framework
8.1.3.6.5 Competitive scenario
8.1.3.7 Thailand
8.1.3.7.1 Thailand IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.3.7.2 Key country dynamics
8.1.3.7.3 Disease prevalence
8.1.3.7.4 Regulatory framework
8.1.3.7.5 Competitive scenario
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast estimates and forecast, 2018 – 2030 (USD Billion)
8.1.4.2 Brazil
8.1.4.2.1 Brazil IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.4.2.2 Key country dynamics
8.1.4.2.3 Disease prevalence
8.1.4.2.4 Regulatory framework
8.1.4.2.5 Competitive scenario
8.1.4.3 Mexico
8.1.4.3.1 Mexico IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.4.3.2 Key country dynamics
8.1.4.3.3 Disease prevalence
8.1.4.3.4 Regulatory framework
8.1.4.3.5 Competitive scenario
8.1.4.4 Argentina
8.1.4.4.1 Argentina IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.4.4.2 Key country dynamics
8.1.4.4.3 Disease prevalence
8.1.4.4.4 Regulatory framework
8.1.4.4.5 Competitive scenario
8.1.5 MEA
8.1.5.1 MEA market estimates and forecast estimates and forecast, 2018 – 2030 (USD Billion)
8.1.5.2 South Africa
8.1.5.2.1 South Africa IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.5.2.2 Key country dynamics
8.1.5.2.3 Disease prevalence
8.1.5.2.4 Regulatory framework
8.1.5.2.5 Competitive scenario
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.5.3.2 Key country dynamics
8.1.5.3.3 Disease prevalence
8.1.5.3.4 Regulatory framework
8.1.5.3.5 Competitive scenario
8.1.5.4 UAE
8.1.5.4.1 UAE IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.5.4.2 Key country dynamics
8.1.5.4.3 Disease prevalence
8.1.5.4.4 Regulatory framework
8.1.5.4.5 Competitive scenario
8.1.5.5 Kuwait
8.1.5.5.1 Kuwait IVD infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
8.1.5.5.2 Key country dynamics
8.1.5.5.3 Disease prevalence
8.1.5.5.4 Regulatory framework
8.1.5.5.5 Competitive scenario
Chapter 9 COMPETITIVE LANDSCAPE
9.1 Company Categorization
9.2 Strategy Mapping
9.2.1 New product launch
9.2.2 Partnerships
9.2.3 Acquisition
9.2.4 Collaboration
9.3 Key company market share analysis, 2022
9.4 Company Profiles
9.4.1 BD
9.4.1.1 Company overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.2 bioMérieux SA
9.4.2.1 Company overview
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.3 Abbott
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.4 Quidel Corporation
9.4.4.1 Company overview
9.4.4.2 Financial performance
9.4.4.3 Product benchmarking
9.4.4.4 Strategic initiatives
9.4.5 OraSure Technologies, Inc
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.6 Hologic Inc. (Gen Probe)
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 Cepheid (Danaher)
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.8 QIAGEN
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.9 F. Hoffmann-La Roche Ltd.
9.4.9.1 Company overview
9.4.9.2 Financial performance
9.4.9.3 Product benchmarking
9.4.9.4 Strategic initiatives
9.4.10 Siemens Healthcare GmbH
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives
9.4.11 Bio-Rad Laboratories, Inc.
9.4.11.1 Company overview
9.4.11.2 Financial performance
9.4.11.3 Product benchmarking
9.4.11.4 Strategic initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global IVD Infectious Diseases Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Global IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 6 Global IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 7 Global IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 8 Global IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 9 North America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 10 North America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 11 North America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 12 North America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 13 North America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 14 U.S. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 15 U.S. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 16 U.S. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 18 Canada IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 19 Canada IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 20 Canada IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 21 Canada IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 22 Europe IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 24 Europe IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 25 Europe IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 26 Europe IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 27 U.K. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 28 U.K. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 29 U.K. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 31 Germany IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 32 Germany America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 33 Germany America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 35 France IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 36 France IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 37 France IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 38 France IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 39 Spain IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 40 Spain IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 41 Spain IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 42 Spain IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 43 Italy IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 44 Italy IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 45 Italy IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 46 Italy IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 47 Denmark IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 48 Denmark IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 49 Denmark IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 50 Denmark IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 51 Sweden IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 52 Sweden IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 53 Sweden IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 54 Sweden IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 55 Norway IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 56 Norway IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 57 Norway IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 58 Norway IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 59 Asia Pacific IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 60 Asia Pacific IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 61 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 62 Asia Pacific IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 63 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 64 China IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 65 China IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 66 China IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 67 China IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 68 Japan IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 69 Japan IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 70 Japan IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 71 Japan IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 72 India IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 73 India IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 74 India IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 75 India IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 76 South Korea IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 77 South Korea IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 78 South Korea IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 79 South Korea IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 80 Thailand IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 81 Thailand IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 82 Thailand IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 83 Thailand IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 84 Australia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 85 Australia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 86 Australia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 87 Australia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 88 Latin America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 89 Latin America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 90 Latin America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 91 Latin America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 92 Latin America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 93 Brazil IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 94 Brazil IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 95 Brazil IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 96 Brazil IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 97 Mexico IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 98 Mexico IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 99 Mexico IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 100 Mexico IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 101 Argentina IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 102 Argentina IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 103 Argentina IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 104 Argentina IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 105 MEA IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 106 MEA IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 107 MEA IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 108 MEA IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 109 MEA IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 110 South Africa IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 111 South Africa IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 112 South Africa IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 113 South Africa IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 114 UAE IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 115 UAE IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 116 UAE IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 117 UAE IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 118 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 119 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 120 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 121 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 122 Kuwait IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 123 Kuwait IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 124 Kuwait IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 125 Kuwait IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)

★調査レポート[世界の感染症体外診断市場2023-2030：製品別（機器、試薬、ソフトウェア）、技術別、用途別、検査場所別、地域別] (コード：GRV23JUN005)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の感染症体外診断市場2023-2030：製品別（機器、試薬、ソフトウェア）、技術別、用途別、検査場所別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のIn Situハイブリダイゼーション(ISH)市場2024-2030：技術別（FISH、CISH）、プローブタイプ別（DNA、RNA）、製品別（装置、消耗品＆付属品、ソフトウェア、サービス）、用途別、エンドユーザー別、地域別
  • 世界の空間ゲノミクス＆トランスクリプトミクス市場2023-2030：技術別（空間トランスクリプトミクス、空間ゲノミクス）、製品別（消耗品、ソフトウェア）、エンドユーザー別、地域別
  • 医療用3D画像診断装置のグローバル市場2023-2030：ハードウェア、ソフトウェア
  • 世界のテレヘルス（遠隔医療）市場2024-2030：製品タイプ別（ハードウェア、ソフトウェア、サービス）、提供形態別（オンプレミス、ウェブベース）、エンドユーザー別、疾患領域別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆